These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37143158)

  • 1. Stereotactic Body radiotherapy and pedicLE screw fixatioN During one hospital visit for patients with symptomatic unstable spinal metastases: a randomized trial (BLEND RCT) using the Trials within Cohorts (TwiCs) design.
    Huele EH; van der Velden JM; Kasperts N; Eppinga WSC; Grutters JPC; Suelmann BBM; Weening AA; Delawi D; Teunissen SCCM; Verkooijen HM; Verlaan JJ; Gal R
    Trials; 2023 May; 24(1):307. PubMed ID: 37143158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing conVEntional RadioTherapy with stereotactIC body radiotherapy in patients with spinAL metastases: study protocol for an randomized controlled trial following the cohort multiple randomized controlled trial design.
    van der Velden JM; Verkooijen HM; Seravalli E; Hes J; Gerlich AS; Kasperts N; Eppinga WS; Verlaan JJ; van Vulpen M
    BMC Cancer; 2016 Nov; 16(1):909. PubMed ID: 27871280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
    Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Radiotherapy Of MInimally Symptomatic Spinal Disease (PROMISSeD): study protocol for a randomized controlled trial.
    Rothrock RJ; Ozair A; Avendano MC; Herrera S; Appel H; Ramos S; Starosciak AK; Leon-Ariza DS; Rubens M; McDermott MW; Ahluwalia MS; Mehta MP; Kotecha RR
    Trials; 2024 Jan; 25(1):41. PubMed ID: 38217032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Pielkenrood BJ; van der Velden JM; van der Linden YM; Bartels MMT; Kasperts N; Verhoeff JJC; Eppinga WSC; Gal R; Verlaan JJ; Verkooijen HML
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):358-367. PubMed ID: 33333200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative quality-of-life assessment in patients with spine metastases treated with long-segment pedicle-screw fixation.
    Bernard F; Lemée JM; Lucas O; Menei P
    J Neurosurg Spine; 2017 Jun; 26(6):725-735. PubMed ID: 28338450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.
    Doppenberg D; Besselink MG; van Eijck CHJ; Intven MPW; Koerkamp BG; Kazemier G; van Laarhoven HWM; Meijerink M; Molenaar IQ; Nuyttens JJME; van Os R; van Santvoort HC; van Tienhoven G; Verkooijen HM; Versteijne E; Wilmink JW; Lagerwaard FJ; Bruynzeel AME;
    BMC Cancer; 2022 Dec; 22(1):1363. PubMed ID: 36581914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic Radiotherapy Followed by Surgical Stabilization Within 24 h for Unstable Spinal Metastases; A Stage I/IIa Study According to the IDEAL Framework.
    Versteeg AL; van der Velden JM; Hes J; Eppinga W; Kasperts N; Verkooijen HM; Oner FC; Seravalli E; Verlaan JJ
    Front Oncol; 2018; 8():626. PubMed ID: 30619760
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
    Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
    Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET).
    Mercier C; Dirix P; Ost P; Billiet C; Joye I; Vermeulen P; Lievens Y; Verellen D
    BMC Cancer; 2019 Sep; 19(1):876. PubMed ID: 31484505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for osseous low alpha-beta resistant metastases for pain relief-SOLAR-P.
    Nguyen EK; Quan K; Parpia S; Tran S; Swaminath A
    Radiat Oncol; 2021 Sep; 16(1):170. PubMed ID: 34479581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
    Cellini F; Manfrida S; Deodato F; Cilla S; Maranzano E; Pergolizzi S; Arcidiacono F; Di Franco R; Pastore F; Muto M; Borzillo V; Donati CM; Siepe G; Parisi S; Salatino A; D'Agostino A; Montesi G; Santacaterina A; Fusco V; Santarelli M; Gambacorta MA; Corvò R; Morganti AG; Masiello V; Muto P; Valentini V
    Trials; 2019 Oct; 20(1):609. PubMed ID: 31661034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase III trial (STEREO-OS).
    Thureau S; Marchesi V; Vieillard MH; Perrier L; Lisbona A; Leheurteur M; Tredaniel J; Culine S; Dubray B; Bonnet N; Asselain B; Salleron J; Faivre JC
    BMC Cancer; 2021 Feb; 21(1):117. PubMed ID: 33541288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic versus conventional radiotherapy for pain reduction and quality of life in spinal metastases: study protocol for a randomized controlled trial.
    Braam P; Lambin P; Bussink J
    Trials; 2016 Feb; 17():61. PubMed ID: 26829933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Redmond KJ; Sciubba D; Khan M; Gui C; Lo SL; Gokaslan ZL; Leaf B; Kleinberg L; Grimm J; Ye X; Lim M
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):261-268. PubMed ID: 31628959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial.
    Rief H; Katayama S; Bruckner T; Rieken S; Bostel T; Förster R; Schlampp I; Wolf R; Debus J; Sterzing F
    Trials; 2015 Jun; 16():264. PubMed ID: 26054533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
    Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
    BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC).
    Pavic M; Niyazi M; Wilke L; Corradini S; Vornhülz M; Mansmann U; Al Tawil A; Fritsch R; Hörner-Rieber J; Debus J; Guckenberger M; Belka C; Mayerle J; Beyer G
    Radiat Oncol; 2022 Jan; 17(1):18. PubMed ID: 35078490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life Following Stereotactic Body Radiotherapy
    Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; El Shafie RA; Nicolay NH; Debus J; Rief H
    Anticancer Res; 2018 Aug; 38(8):4961-4968. PubMed ID: 30061276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.